BACKGROUND/AIMS: The present study examined the relationship between microvascular complications and cognitive decline and the development of structural brain abnormalities over a period of 4 years in patients with type 2 diabetes mellitus (T2DM). METHODS: Sixty-eight elderly patients with T2DM had 2 cognitive assessments with a 4-year interval. Two MRI scans, performed at the same time as the cognitive assessments, were available from 55 patients. Changes in cognitive performance over time were expressed as a regression-based index (RBI). Automated volumetric measurements of total brain, lateral ventricles and white matter hyperintensities were performed. The relationship between baseline microvascular complications [diabetic retinopathy, peripheral neuropathy or albuminuria (micro- or macroalbuminuria)] and cognition and brain volumes was examined with linear regression analyses adjusted for age and sex (for cognition also for IQ). RESULTS: At baseline, diabetic retinopathy was present in 18% of patients, peripheral neuropathy in 36%, albuminuria in 15%. Retinopathy or neuropathy were not significantly associated with baseline cognition or brain volumes, or changes in these measures over time. Albuminuria was associated with a lower composite RBI score, indicating accelerated cognitive decline (adjusted mean difference between patients with or without albuminuria: -0.58, 95% CI -0.85 to -0.31, p < 0.001). CONCLUSION: Albuminuria predicted accelerated cognitive decline in patients with T2DM, but other microvascular complications were unrelated to accelerated cognitive decline or brain MRI abnormalities.
BACKGROUND/AIMS: The present study examined the relationship between microvascular complications and cognitive decline and the development of structural brain abnormalities over a period of 4 years in patients with type 2 diabetes mellitus (T2DM). METHODS: Sixty-eight elderly patients with T2DM had 2 cognitive assessments with a 4-year interval. Two MRI scans, performed at the same time as the cognitive assessments, were available from 55 patients. Changes in cognitive performance over time were expressed as a regression-based index (RBI). Automated volumetric measurements of total brain, lateral ventricles and white matter hyperintensities were performed. The relationship between baseline microvascular complications [diabetic retinopathy, peripheral neuropathy or albuminuria (micro- or macroalbuminuria)] and cognition and brain volumes was examined with linear regression analyses adjusted for age and sex (for cognition also for IQ). RESULTS: At baseline, diabetic retinopathy was present in 18% of patients, peripheral neuropathy in 36%, albuminuria in 15%. Retinopathy or neuropathy were not significantly associated with baseline cognition or brain volumes, or changes in these measures over time. Albuminuria was associated with a lower composite RBI score, indicating accelerated cognitive decline (adjusted mean difference between patients with or without albuminuria: -0.58, 95% CI -0.85 to -0.31, p < 0.001). CONCLUSION:Albuminuria predicted accelerated cognitive decline in patients with T2DM, but other microvascular complications were unrelated to accelerated cognitive decline or brain MRI abnormalities.
Authors: Christina E Hugenschmidt; Fang-Chi Hsu; Satoru Hayasaka; J Jeffrey Carr; Barry I Freedman; David L Nyenhuis; Jeff D Williamson; Donald W Bowden Journal: J Diabetes Complications Date: 2013-05-07 Impact factor: 2.852
Authors: Sophie M Heringa; Willem H Bouvy; Esther van den Berg; Annette C Moll; L Jaap Kappelle; Geert Jan Biessels Journal: J Cereb Blood Flow Metab Date: 2013-04-17 Impact factor: 6.200
Authors: Stefano Tarantini; Andriy Yabluchanksiy; Gábor A Fülöp; Peter Hertelendy; M Noa Valcarcel-Ares; Tamas Kiss; Jonathan M Bagwell; Daniel O'Connor; Eszter Farkas; Farzaneh Sorond; Anna Csiszar; Zoltan Ungvari Journal: Geroscience Date: 2017-12-14 Impact factor: 7.713
Authors: Lieza G Exalto; Geert Jan Biessels; Andrew J Karter; Elbert S Huang; Charles P Quesenberry; Rachel A Whitmer Journal: J Alzheimers Dis Date: 2014 Impact factor: 4.472
Authors: Joshua I Barzilay; Timothy M Morgan; Anne M Murray; R Nick Bryan; Jeff D Williamson; Adrian Schnall; Lenore J Launer Journal: J Gerontol A Biol Sci Med Sci Date: 2015-11-19 Impact factor: 6.053